Vimarsana
Biggest News Aggregation in the World

Watch Study News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Watch Study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Watch Study Today - Breaking & Trending Today

'Use it or lose it' bill that could strip inactive Texas voters' registration advances - Vimarsana News

'Use it or lose it' bill that could strip inactive Texas voters' registration advances

The Texas Senate passed a bill designed to clean up election registration lists but could have the added consequence of removing inactive voters from...

London Underground wasn't a Covid super-spreader because of masks and ventilated carriages - Vimarsana News

London Underground wasn't a Covid super-spreader because of masks and ventilated carriages

Use of the tube has fluctuated massively during the pandemic, with experts and politicians warning it was a breeding ground for the virus.

Where you are most likely to catch Covid according to experts - Vimarsana News

Where you are most likely to catch Covid according to experts

YOU'RE most likely to catch Covid while going to the shops, experts have warned as they released a list of the most contagious activities.A Government

Shopping is RISKIEST activity for getting Covid - Vimarsana News

Shopping is RISKIEST activity for getting Covid

SAGE 's Virus Watch Study examined the day-to-day activities of more than 10,000 people in England and Wales between September and November 2021.

More than 96% of Britons develop Covid antibodies after one dose of vaccine - Vimarsana News

More than 96% of Britons develop Covid antibodies after one dose of vaccine

More than 96 per cent of Britons develop Covid antibodies after one Pfizer or AstraZeneca vaccine, real world data suggests. A study of 8,517 people in England and Wales found 96.42 per cent of adults developed the virus-fighting proteins 28 to 34 days after their first dose. It rose to more than 99 per cent seven to 14 days after a second dose of either jab, the University College London (UCL) research found. The real world study looked at 13,232 antibody samples from people with an average of 65, to reflect the older age groups first given a vaccine. The fact every participant had antibodie...